ISRCTN83971151已完成3 期
An international randomized trial of additional treatments for COVID-19 in hospitalized patients who are all receiving the local standard of care
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 11,266
研究概览
简要总结
2020 Interim results article in https://doi.org/10.1101/2020.10.15.20209817 interim results in preprint (added 19/10/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33264556/ interim results for remdesivir, hydroxychloroquine, lopinavir and interferon (added 25/03/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35512728/ final results and updated meta-analyses (added 06/05/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adults (aged =18 years) hospitalized with definite COVID-19
- •2. Not already receiving any of the study drugs
- •3. Without known allergy or contraindications to any of them (in the view of the physician responsible for their care)
- •4. Without anticipated transfer within 72 h to a non-study hospital
- •Patients invited to join the study will be those who are admitted to a collaborating hospital; no wider recruitment efforts are expected
排除标准
- •Current exclusion criteria as of 21/04/2020:
- •1. Any of the available study drugs are contra-indicated (e.g. because of patient characteristics, chronic liver or heart disease, or some concurrent medication)
- •2. Declined to participate in the study
- •Previous exclusion criteria:
- •1. Any of the available study drugs are contra-indicated (e.g. because of patient characteristics, chronic liver or heart disease, or some concurrent medication)
- •2. Pregnant
- •3. Declined to participate in the study
研究者
相似试验
进行中（未招募）
1 期
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careEUCTR2020-001366-11-LVWorld Health Organization100,000
进行中（未招募）
1 期
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19EUCTR2020-001366-11-IEWorld Health Organisation100,000
进行中（未招募）
1 期
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careCOVID-19EUCTR2020-001366-11-ESFIB-HCSC100,000
进行中（未招募）
1 期
An international randomised trial of additional treatments for COVID-19 inhospitalised patients who are all receiving the local standard of careEUCTR2020-001366-11-ROMinistry of Health100,000
进行中（未招募）
1 期
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of careEUCTR2020-001366-11-SKMinisterstvo Zdravotníctva Slovenskej republiky100,000